UnitedHealth Group Second Quarter Highlights

Go back to UnitedHealth Group Second Quarter Highlights

UnitedHealth Group (UNH) PT Raised to $205 at Oppenheimer Following Strong 2Q

July 19, 2017 9:43 AM EDT

Oppenheimer raised its price target on UnitedHealth Group (NYSE: UNH) to $205.00 (from $203.00) while maintaining a Outperform rating following the company's 2Q. UNH reported EPS of $2.46, ahead of Street estimates of $2.38. The beat was driven by continued strong medical cost management, while Optum continues to... More

Cantor Fitzgerald Remains Bullish on UnitedHealth Group (UNH) Following 2Q Release

July 19, 2017 7:45 AM EDT

Cantor Fitzgerald reiterated an Overweight rating and $208.00 price target on UnitedHealth Group (NYSE: UNH) following the company's 2Q earnings report. 2Q17 revenue of $50.1 billion was above the FactSet consensus expectations of $50 billion. Results benefited from efforts to reduce its exposure to ACA individual... More

UnitedHealth Group (UNH) Tops Q2 EPS by 8c; Boosts Outlook

July 18, 2017 5:58 AM EDT

UnitedHealth Group (NYSE: UNH) reported Q2 EPS of $2.46, $0.08 better than the analyst estimate of $2.38. Revenue for the quarter came in at $50.1 billion versus the consensus estimate of $50.06 billion.

"Continued strong revenue growth from new business and exceptional customer retention reflects the confidence... More